COVID-19 and National Institutes of Health

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/20/2021 All Americans Now Eligible for COVID-19 Vaccine All Americans Now Eligible for COVID-19 Vaccine By Samuel Allegri LikeThe Biden administration is now delivering on a promise from former President Donald Trump: all Americans are eligible as of Monday to get a COVID-19 vaccine.‚AuI have good news. Everybody is eligible, as of today, to get the vaccine,‚Au President Joe Biden said in a video posted on Monday morning.In a , National Institutes of ...
4/19/2021 NIH funds new COVID-19 testing initiative to get students back to classrooms in vulnerable areas The National Institutes of Health is awarding millions of dollars to nearly a dozen schools across the country to build evidence on how students and teachers can safely return to school amid the COVID-19 pandemic.Ten institutions in eight states, all in vulnerable and underserved areas, are getting a portion of $33 million to be involved. The project is a COVID-19 testing initiative in which researchers hope to ...
4/19/2021 Links and Phone Numbers for Covid-19 Vaccination Clinics Links and Phone Numbers for Covid-19 Vaccination Clinics By 0 99 FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one ...
4/19/2021 WV gets federal funding to detect, combat COVID-19 variants ... Apr 19, 2021 / 11:14 AM 01:11 PM EDTFILE ‚Ai This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow ... a serious inflammatory illness linked to the coronavirus had initial COVID-19 infections with no symptoms or only mild ones, new U.S. research shows. (NIAID-RML via AP, File)WASHINGTON, D.C. (WOWK) ‚Ai West Virginia ...
4/19/2021 Moderna's mRNA technology could help in the decades-long search for an HIV vaccine Yahoo News Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images Moderna's mRNA tech ... the global HIV/AIDS epidemic.Working in collaboration with the National Institutes of Health, Scripps Research, the Gates Foundation, and other partners, Moderna said it would begin testing two HIV vaccine candidates in humans by ...
4/19/2021 What Dikembe Mutombo, The NBA, Kaiser Permanente Are Doing About Covid-19 Vaccine Inequities ... Grady ‚A¶ [+] Memorial Hospital in Atlanta, GA and Phoebe Putney Hospital in Albany, Georgia, which were both hit hard by Covid-19. (Photo: Courtesy of the NBA) Courtesy of the NBADikembe Mutombo has been ... school has been awarded a $40 million grant from the National Institutes of Health (NIH) to address how the Covid-19 pandemic was disproportionately affecting Black Americans and other communities of color in the U.S ...
4/19/2021 What Dikembe Mutombo, The NBA, Kaiser Permanente Are Doing About Covid-19 Vaccine Inequities Forbes ... Covid-19 vaccine is one shot that Mutombo certainly didn‚Aot want to block.In fact, quite the opposite. Mutombo made it a point (pun intended) to get his first dose of the Covid-19 vaccine at the Morehouse School of Medicine in Atlanta, Georgia. Why Morehouse? Well, the medical school has been awarded a $40 million grant from the National Institutes of Health (NIH) to address how the Covid ...
4/19/2021 ‘Masks Are Dirty, Dangerous, Dehumanizing’ ... billionaires have launched a concerted campaign to discredit a scientific study that damns face masks as not just ineffective against COVID-19, but as dirty, dangerous and dehumanizing. Congresswoman Marjorie Taylor Greene wears a protest ... division of the National Library of Medicine (NLM) at the National Institutes of Health (NIH) and, together with the collective research components of NIH, constitutes "the largest biomedical research facility in the world."The Poynter ...
4/17/2021 Washington University researchers to design detectors of airborne SARS-CoV-2 As the COVID-19 pandemic surged last summer and contact tracers struggled to identify sources of infections, John Cirrito , PhD, associate professor of neurology at Washington University School of Medicine in St. Louis, and Carla ... the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health (NIH), the team has two devices in the works. One is an aerosol detector designed to continuously monitor air quality in ...
4/16/2021 NIH funds COVID-19 testing plan to get children back in school | FierceBiotech FierceBiotech Over the past year, the National Institutes of Health has led ‚AuShark Tank‚Au-style competitions and funded radical approaches to help develop COVID-19 testing into a more seamless, ubiquitous part of daily life.Now, the NIH is looking to steer those efforts, plus new government money, toward making it safer to return to classrooms, starting in school districts with the most vulnerable children.It‚Aos beginning with $33 ...
4/16/2021 Experimental antiviral for COVID-19 effective in hamster study ... National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings. advertisementIn their study, published in the journal Nature Communications , the scientists found MK-4482 ...
4/15/2021 Sarasota Memorial Hospital kicks off study in search of better weapons against COVID-19 ... COVID-19 patient. "It‚Aos real and it can happen to anybody," she warns. AdvertisementSarasota Memorial Hospital hopes to lead the way in stopping the inflammatory response with a new drug trial studying the use of anti-CD14 monoclonal antibodies.Sponsored and funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, the randomized, double-blind, placebo-controlled study will enroll between ...
4/15/2021 Navarro: Clear signs show Fauci is ‚Äòfather of the pandemic‚Äô; Mnuchin blocked Trump commission ... Follow on Facebook Print This Postby WorldTribune Staff , April 15, 2021Mounting evidence pointing to laboratory origins of the Covid-19 virus in Wuhan, China implicates Dr. Anthony Fauci, said economist Peter Navarro, an ... almost certainly is ‚Ai then Dr. Anthony Fauci of the National Institutes of Health must assume significant responsibility for a global pandemic that has killed over half-a-million Americans, kicked tens of millions of ...
4/15/2021 Cardiothoracic surgeons mobilised for COVID-19 research Cardiothoracic surgeons mobilised for COVID-19 research 15th April 2021 91The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising resources for COVID-19 research has seen the network recognised as the gold standard for performance across all of the National Institutes of Health (NIH)-sponsored research networks.The network was established 15 years ago through a collaboration with the National, Heart, Lung, and Blood Institute (NHLBI), National ...
4/15/2021 NIH director says J&J vaccine pause will give researchers time to do more study on certain groups - Local News 8 The pause on the Johnson & Johnson Covid-19 vaccine will allow researchers to investigate a potential link to severe blood clotting events, particularly whether certain types of people are more susceptible, National Institutes of Health Director Dr. Francis Collins said Wednesday.The Centers for Disease Control and Prevention and FDA recommended a pause on use of Johnson & Johnson‚Aos vaccine, following six reported US cases of a rare and severe ...
4/14/2021 NC COVID-19 April 14 update: Over 2k new cases reported; infection rate stands at 7.6% | WAVY.com ... EDT / Updated: Apr 14, 2021 / 04:37 PM EDTFILE ‚Ai This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow ... a serious inflammatory illness linked to the coronavirus had initial COVID-19 infections with no symptoms or only mild ones, new U.S. research shows. (NIAID-RML via AP, File)CHARLOTTE, NC (FOX 46 CHARLOTTE/WAVY ...
4/14/2021 AstraZeneca, Sanguina to develop app for bloodless blood testing | FierceBiotech FierceBiotech ... COVID-19 test with Scanwell HealthHemoglobin is the main protein found in red blood cells, tasked with carrying oxygen throughout the body. Low levels of hemoglobin and red blood cells can result in anemia, and severe cases of anemia can contribute to chronic kidney disease (CKD).According to the National Institutes of Health (NIH), more than one in every seven of the estimated 37 million American adults with CKD ...
4/13/2021 More Than 1 In 10 Children With Covid Are Hospitalized | Kaiser Health News Kaiser Health News ... suffering long covid too, and at least five hospitals are starting clinics.CIDRAP: Study Finds 12% Of US children With COVID-19 Are Hospitalized Among a cohort of 20,714 US children with COVID-19, more ... to help kids with lingering COVID-19 illness as the National Institutes of Health and the Centers for Disease Control and Prevention mount a massive, nationwide study of long-haul COVID that includes children. While ...
4/13/2021 A Mystery Under Study: How, Why And When COVID Vaccines Aren’t Fully Protective NPR ... COVID-19 vaccine when it opened in mid-March. Though some relatively rare cases of coronavirus infection have been documented despite vaccination, "I don't see anything that changes our concept of the vaccine and its efficacy," says Dr. Anthony Fauci of the National Institutes of Health.Ginger Eatman thought she was safe after getting her second COVID-19 vaccination in February. But she kept wearing her mask, using hand sanitizer ...
4/12/2021 Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV‚Ñ¢ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 PR Newswire ... in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infectionRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced positive data from a Phase ... Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The trial enrolled 204 individuals without any COVID-19 symptoms who tested positive for SARS-CoV-2 but did not ...
4/12/2021 Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV‚Ñ¢ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 | Markets Insider Business Insider ... in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infection Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive data from a Phase ... Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The trial enrolled 204 individuals without any COVID-19 symptoms who tested positive for SARS-CoV-2 but did not ...
4/12/2021 Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV‚Ñ¢ (casirivimab with imdevimab) | Markets Insider Business Insider ... COVID-19 infection among household contacts of SARS-CoV-2 infected individuals. The trial, which was jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), met its primary and key secondary endpoints, showing that REGEN-COV 1,200 mg administered subcutaneously (SC) reduced the risk of symptomatic infections by 81% in those who were not infected when they entered the ...
4/12/2021 Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV‚Ñ¢ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 Yahoo News ... in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infectionRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive data from a Phase ... Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The trial enrolled 204 individuals without any COVID-19 symptoms who tested positive for SARS-CoV-2 but did not ...
4/12/2021 Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV(TM) (casirivimab with imdevimab) | 2021-04-12 | Press Releases | Stockhouse ... COVID-19 infection among household contacts of SARS-CoV-2 infected individuals. The trial, which was jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), met its primary and key secondary endpoints, showing that REGEN-COV 1,200 mg administered subcutaneously (SC) reduced the risk of symptomatic infections by 81% in those who were not infected when they entered the ...
4/12/2021 Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV(TM) (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19 | 2021-04-12 | Press Releases | Stockhouse ... in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infectionRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive data from a Phase ... Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The trial enrolled 204 individuals without any COVID-19 symptoms who tested positive for SARS-CoV-2 but did not ...